Tag - KMDA

Developments

Kamada IgG therapy cleared for compassionate COVID-19 use in Israel

Kamada (NASDAQ, TASE:KMDA) completed manufacturing of the first batch of its plasma-derived immunoglobulin (IgG) product for the treatment of COVID-19 and the initial vials are available for compassionate use in Israel...

June 17, 2020

Developments

Kamada enrolls first patient in Phase 3 alpha-1 antitrypsin deficiency trial

Kamada (NASDAQ, TASE:KMDA) randomized the first patient in a pivotal clinical trial evaluating its inhaled alpha-1 antitrypsin (AAT) therapy for the treatment of alpha-1 antitrypsin deficiency (AATD). AATD is an...

December 17, 2019

Developments

Kamada in pact with Alvotech to commercialization 6 biosimilars in Israel

Kamada (NASDAQ, TASE:KMDA) agreed to commercialize Alvotech’s portfolio of six biosimilar product candidates in Israel, pending approval of the Israeli Ministry of Health (IMOH). Alvotech’s pipeline includes biosimilar...

December 2, 2019

Tag - KMDA

Kamada IgG therapy cleared for compassionate COVID-19 use in Israel

Kamada enrolls first patient in Phase 3 alpha-1 antitrypsin deficiency trial

Kamada in pact with Alvotech to commercialization 6 biosimilars in Israel

General

More